chebulinic acid has been researched along with Retinal Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angayarkanni, N; Shanmuganathan, S | 1 |
1 other study(ies) available for chebulinic acid and Retinal Neovascularization
| Article | Year |
|---|---|
Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Benzopyrans; Cell Line; Chick Embryo; Dose-Response Relationship, Drug; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Gallic Acid; Glucosides; Hydrolyzable Tannins; Inflammation Mediators; Macaca mulatta; Matrix Metalloproteinase 9; Molecular Docking Simulation; Neovascularization, Physiologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Protein Binding; Receptors, Tumor Necrosis Factor, Type I; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha | 2018 |